2018 China Interchange Presentations

Thank you for attending the 2018 China Interchange. You will find a link to each of the presentation slides from the event below.

Note: Presentations are subject to copyright and may not be used without written consent of CDISC or its affiliates.
 

Session 1: Opening Plenary & Keynotes

Opening Remarks
David R. Bobbitt, CDISC President and CEO; and David Hardison, CDISC Board Past-Chair

Keynote Presentation - Data Standardization from a Statistical Review Perspective
Jun Wang, CDE (NMPA)

U.S. Regulatory Update
Ron Fitzmartin, FDA-CDER

Japan Regulatory Update
Yuki Ando, PMDA

Session 2: The Past, Present & Future of CDISC Standards

Global Standards for a Greater Impact on Global Health
Peter Van Reusel, CDISC CSO

SHARE 2.0
Sam Hume, CDISC VP, Data Science

CDISC Myths & Truths: Creating Clarity
Bess LeRoy, CDISC Head of Standards Development

Session 3: Submission Update from CNDA

Data Submission in China: Current Status and Future
Victor Wu, C3C

Data Standardization Implementation in China Study - Practice and Proposal
Chao Wang & Shenglin Zhang, C3C

Session 4: Compliance & Regulatory Topics

ADaM Standards - Implementation, Challenges and FAQs
Guowei Wu, MSD

CDISC Conformance Checking Introduction and Implementation
Jialei Zhang, dMed

Traceability of Study Data from Collection Through to Analysis
Jason Guan, Novartis

Session 5: Intro to CDISC Standards & User Group Updates

Update on C3C Achievements, User Groups and Workgroups
John Wang, C3C

Japan CDISC Coordinating Committee (J3C) Update
Yoshiteru Chiba, J3C

Update of CDISC CDASH 2.0
Lily Zhao, PAREXEL

Session 6: Panel Discussion

Session 7, Track A: Use Cases for CDISC Standards & Technology

The WHODrug B3/C3 Formats and CDISC SDTM Compliance
Damon Fahimi, UMC

Best Practices for Increasing Accuracy and Efficiency of Database Build
Tianjiao Li, FMD K&L

Implementation of Trial Design Model (TDM) in Adaptive Trial Design
Song Gao, Jiangsu Hengrui Medicine Co., Ltd.

Good Practices for FDA/PMDA Define Package Preparation
Jia Yang, Novartis

Session 7, Track B: Process, Efficiency and Tools

Intelligent Assessment and Expansion of Clinical Trial Data in CDISC Format
Wenjun Bao, JMP Life Sciences

Optimizing SDTM Process by Tool Invention: Define-XML Creator and SDTM Validator in China
Ruiling Peng, Improve-Quality Medical

ADRG Automation Using R Markdown
Minhan Li, dMed

How to report SAE/ADR data with E2B R3 format
Song Li, ForceClouds

Session 8, Track A: Use Cases for CDISC Standards & Technology

Frequently Asked Questions in CDISC Implementation
Victor Wu, Data Science Express

Introduction of SAS Clinical Standards Toolkit
Yaohua Huang, Data Science Express; and Qinghua Wang, SAS Institute

Implementation of CDISC Standard in the PK Data Analysis
Billy Xin, Mosim Medical

Automation of Statistical Analyses Based on ADaM
Xiang Liu, Hua Medicine

Session 8, Track B: Process, Efficiency and Tools

Optimized SDTM Process and Submission Package Preparation with Pattern Macro
Zhenglong Tian, PAREXEL

Mapping the Company’s Legacy Data Model to CDISC
Dawei Zheng, Medidata

Automatic Conversion of the Raw Data to SDTM by Using SAS & VBA
Danjjie Wang, TrustCRO

An Efficient Way to Generate, Update and Maintain Define-XML 2.0
Yuan Wang, FMD K&L

Session 9, Part I: CDISC Standards for Therapeutic Areas

eSubmission Package Preparation for US FDA/Canada HA
Yanhong Li, MSD

Applicability Analysis of CDISC Standards to Clinical Evaluation Data in Guidance for IND of TCM Clinical Research
Joy Li, Xiyuan Hospital

The Development of the Acupuncture Therapeutic Area Standard
Geng Li, KUMCR, Guangdong Provincial Hospital of Chinese Medicine

Implementation of the Time-to-Event Model in Analysis of Clinical Trials
Hongfang Zhou, Jiangsu Hengrui Medicine Co., Ltd.

Session 9, Part II: Therapeutic Areas, Traditional Chinese Medicine & SEND

Updates on TCM-CAD-Angina TAUG and SDTM Standards in Therapeutic Area for Kidney Transplant
Jordan Li, NIH, NCI-EVS

Example on SDTM and ADaM Standards in Neuroscience Therapeutic Area for Major Depressive Disorder
Ella Cheng, Johnson & Johnson

Beginning to End Standards and Therapeutic Areas Projects
Bess LeRoy, CDISC Head of Standards Development

SEND- History, Current Development, and The Vision
Lou Ann Kramer, CDISC Senior Director, Standards Development

Session 10: Panel Discussion